BD Completes Bard Acquisition, Creating New Global Health Care …
2017年12月29日 · BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (NYSE: BCR), creating a new health...
Our Company | BD
2017 BD acquired C. R. Bard, a medical device company founded in 1907 in Covington, Georgia. 2015 BD became the first to integrate IV pumps with electronic health records. 2015 BD acquired CareFusion, a San Diego, California-based medical technology company specializing in two areas: reducing medication errors and prevention of health care ...
BD To Acquire Bard For $24 Billion
2017年4月23日 · Bard's clinically differentiated offerings create more meaningful scale and relevance for BD in high-growth categories of oncology and surgery. Bard will expand BD's focus on the treatment of disease states beyond diabetes to include peripheral vascular disease, urology, hernia and cancer.
Advancing the World of Health | BD
At BD, we seek to usher in a new era of healthcare by bringing medical products, capabilities and solutions to every corner of the world.
BD Newsroom - Press releases
2017年4月23日 · Bard’s clinically differentiated offerings will create more meaningful scale and relevance for BD in high-growth categories of oncology and surgery. Bard will expand BD’s focus on the treatment of disease states beyond diabetes to include peripheral vascular disease, urology, hernia and cancer.
Vascular access management - BD
A catheter-related bloodstream infection (CRBSI) is when the catheter is identified as the source of the infection. 2* Signs and symptoms to look for include erythema; edema; any pain or tenderness or drainage and/or fever. 2** There are extraluminal and intraluminal areas that could be potential spots for contamination, leading to CRBSIs from risk of breaking asepsis during …
Bard Mesh - BD
With more than 50 years of clinical experience, Bard® Mesh is the Gold Standard product to be used in a "tension-free" hernia repair. It can be tailored preoperatively and customized to any unique situation.
About us - BD
We support the heroes on the frontlines of health care by developing innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for health care providers. In 2017, BD welcomed C. R. Bard and its products into the BD family.
BD Completes Bard Acquisition, Creating New Global Health Care …
FRANKLIN LAKES, N.J., Dec. 29, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (NYSE: BCR), creating a new health care industry leader with approximately $16 billion in annualized revenue.
Products - BD
Products; Solutions. Administrator. Ambulatory Surgery Center Solutions; BD Hypodermic Needle and Syringe Solutions; Diagnostic Accuracy and Efficiency